Content by The Scientist

Mendel upended? I was interested in this story1 when the 2005 paper came out, suggesting that Arabidopsis mutants could revert to wild type, and I started doing some experiments to test Susan Lolle and Robert Pruitt's ideas. My early data seemed to support the notion that reversion was happening (although it was not consistent with RNA-mediated reversion). When Steve Jacobsen's paper came out I decid

Credit: Right: courtesy of Australian Animal Health Laboratory" /> Credit: Right: courtesy of Australian Animal Health Laboratory GRANT ME GRANTS » In "Click To Submit", we present tips for how to submit grants electronically. For some in-person advice, enroll in one of eight two-day grant writing courses offered in April by Grant Writing USA. Courses will take place across the cou

The Scientist posted a Web-based questionnaire and invited readers of The Scientist and registrants on The Scientist web site who identified themselves as non-tenured life scientists working in academia or other non-commercial research organizations to respond. We received 3,086 usable responses. We asked respondents to assess their working conditions and environments by indicating their level of agreement with 44 criteria in 11 different areas. They also

var FO = { movie:"https://images.the-scientist.com/supplementary/flash/54200/54200.swf", width:"520", height:"680", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Slideshow: Mendel upended? For the February issue, Andrea Gawrylewski traveled to the University of Waterloo, Ontario, to check in on Arabidopsis researcher Susan Lolle's ongoing experiments. Lolle and colleagues reported in 2005 that a mutant Arabidopsis plant could revert

For an upcoming Lab Tools article, tell us how you've tackled your trickiest PCR

Survey closes Friday, March 7, so log your vote today

Which company will take first place honors this year? Cast your vote today

Cephalon: Twenty Years of Building a Life Sciences Enterprise In 1987, a young researcher decided to seize the opportunity to build on the promise of molecular biology that had helped to create a critical mass of companies in the biotech arena. At that time, research into central nervous system disorders was in its infancy and Cephalon founder, scientist and CEO, Frank Baldino, Jr. PhD envisioned creating a different kind of company that would be a hybri

Fox Chase Cancer Center "I strongly believe that there will be a totally different way to treat cancer patients in the next 10 years," declared Michael V. Seiden, MD, PhD, shortly after he became president and CEO of Fox Chase Cancer Center in June 2007. "I think tumors will be removed and analyzed in a much more molecularly-based way. This is already being done at the research level, but in 10 years, therapies will be selected for people based on the molecula

Introduction from Regional CEOs Dear Readers: As the CEOs of leading life science companies located in Greater Philadelphia, we are proud to be a part of this publication that showcases the rapidly growing life sciences industry in our region. The Greater Philadelphia region, which encompasses 11 counties in three states - southern New Jersey, southeastern Pennsylvania, and northern Delaware - is home to an unparalleled combination of resources supporting biopharmaceutic

Introduction from James C. Greenwood Dear Readers: As the president and CEO of the Biotechnology Industry Organization (BIO), it is my privilege to represent an industry that is saving and improving the lives, health, and well-being of billions of people around the world. Innovative biotechnology products are transforming the fight against disease, hunger, and pollution. I am proud to be associated with the dedicated men and women who make up the biotechnology industr

Successful Strategies In this section you will meet some of the region's most successful entrepreneurs who discuss how their companies first stayed alive, then flourished over time. The region is well-known for its collaborative spirit, but collaboration is also a strategic move that has brought forth innovative technologies in Greater Philadelphia. One such long-term partnership is on its way to a treatment for Alzheimer's disease and schizophrenia. Margaret F

Rutgers University - Camden: Anchoring Bioscience Research in Camden and the Delaware Valley The early home of recorded sound and the birthplace of technological innovations that changed the world, the City of Camden is establishing a new role for itself as a thriving center for the biosciences in the metro Philadelphia region and the State of New Jersey. Rutgers, The State University of New Jersey, anchors that growing reputation. Respected internationally for

Collaboration Brings Research Breakthroughs Lisa Staiano-Coico, Provost and Senior Vice President for Academic Affairs At Temple University, interdisciplinary collaboration plays a vital role in the success of research programs. Seventeen schools and colleges, along with specialized research centers and institutes, make Temple an excellent place for investigators to exchange ideas, assist one another in the design of joint projects, and benefit from the existen

COOL CONNECTIONS "Somehow, suddenly, Philadelphia got cool." This quote comes from a travel magazine but it applies equally well to the life sciences in Greater Philadelphia. The city has been transformed "to a place teeming with stellar restaurants, comfortable cafes, world-class museums and some stunning architecture." Likewise, the region has an abundance of top-drawer academic institutions, a heavyweight pharma presence, a developing biotech base, and an impre